HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plitz, T. Articles by Chvatchko, Y. Search for Related Content PubMed PubMed Citation Articles by Plitz, T. Articles by Chvatchko, Y.

IL-18 Binding Protein Protects Against Contact Hypersensitivity

Thomas Plitz^1,*, Pierre Saint-Mézard, Masataka Satho, Susanne Herren^2,*, Caroline Waltzinger^*, Marcelo de Carvalho Bittencourt^3,*, Marie H. Kosco-Vilbois^2,* and Yolande Chvatchko^*

^* Department of Immunology, Serono Pharmaceutical Research Institute, Geneva, Switzerland; and Institut National de la Santé et de la Recherche Médicale, Unité 503, Lyon, France

Allergic contact dermatitis, the clinical manifestation of contact hypersensitivity, is one of the most common disorders of the skin. It is elicited upon multiple cutaneous re-exposure of sensitized individuals to the sensitizing agent. In this study, we demonstrate that using IL-18 binding protein (IL-18BP) to neutralize IL-18 significantly reduced clinical symptoms in a murine model of contact hypersensitivity. Furthermore, IL-18BP alleviated the relapses during established disease, as indicated by significant protection during re-exposure of mice that had previously undergone a contact hypersensitivity response without treatment. Although edema was not influenced, IL-18BP reduced the number of T cells homing to sites of inflammation, resulting in diminished local production of IFN-. Thus, by preventing the accumulation of effector T cells to the target tissue, IL-18BP appears to be a potent protective mediator to counter skin inflammation during contact hypersensitivity. Taken together with the evidence that IL-18 is present in tissue samples of the human disease, our data reinforces IL-18BP as a candidate for this therapeutic indication.

This article has been cited by other articles:

				B. Krumm, X. Meng, Y. Li, Y. Xiang, and J. Deng Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein PNAS, December 30, 2008; 105(52): 20711 - 20715. [Abstract] [Full Text] [PDF]

				H. Wu, M. L. Craft, P. Wang, K. R. Wyburn, G. Chen, J. Ma, B. Hambly, and S. J. Chadban IL-18 Contributes to Renal Damage after Ischemia-Reperfusion J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2331 - 2341. [Abstract] [Full Text] [PDF]

				C. Antonopoulos, M. Cumberbatch, J. B. Mee, R. J. Dearman, X.-Q. Wei, F. Y. Liew, I. Kimber, and R. W. Groves IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis J. Leukoc. Biol., February 1, 2008; 83(2): 361 - 367. [Abstract] [Full Text] [PDF]

				S. Nakae, Y. Iwakura, H. Suto, and S. J. Galli Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17 J. Leukoc. Biol., May 1, 2007; 81(5): 1258 - 1268. [Abstract] [Full Text] [PDF]

				K. Wyburn, H. Wu, J. Yin, M. Jose, J. Eris, and S. Chadban Macrophage-derived interleukin-18 in experimental renal allograft rejection Nephrol. Dial. Transplant., April 1, 2005; 20(4): 699 - 706. [Abstract] [Full Text] [PDF]